TELA Bio Price Target Maintained With a $14.00/Share by Canaccord Genuity
TELA Bio Analyst Ratings
CCORF Maintains TELA Bio(TELA.US) With Buy Rating, Maintains Target Price $14
Buy Rating Affirmed for TELA Bio Amid Strategic Positioning and Innovative Hernia Repair Product Line
Lake Street Sticks to Its Buy Rating for TELA Bio (TELA)
Analysts Are Bullish on Top Healthcare Stocks: TELA Bio (TELA), Rezolute (RZLT)
Analysts Offer Insights on Healthcare Companies: Evogene (EVGN), TELA Bio (TELA) and InfuSystem Holdings, Inc. (INFU)
TELA Bio Analyst Ratings
TELA Bio (TELA) Gets a Buy From Piper Sandler
Lake Street Reaffirms Their Buy Rating on TELA Bio (TELA)
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)
JMP Securities Reiterates Market Outperform on TELA Bio, Maintains $15 Price Target
TELA Bio Analyst Ratings
Piper Sandler Initiates a Buy Rating on TELA Bio (TELA)
Analysts Offer Insights on Healthcare Companies: TELA Bio (TELA) and Vor Biopharma (VOR)
Strategic Divestiture and Innovative Product Launch Fuel Buy Rating for TELA Bio
Lake Street Reiterates Buy on TELA Bio, Maintains $14 Price Target
TELA Bio Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), TELA Bio (TELA) and Smith & Nephew Snats (SNN)
JMP Securities Maintains Market Outperform on TELA Bio, Lowers Price Target to $15
No Data